THE POTTERIES
TYLERS PLACE, TILEHURST, READING
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 38 | 52 | 73.1% | |
| HF 4 | 2011 | 39 | 51 | 76.5% | |
| HF 4 | 2012 | 37 | 48 | 77.1% | |
| HF 4 | 2013 | 38 | 46 | 82.6% | |
| HF004 | 2014 | 36 | 40 | 90.0% | |
| HF004 | 2015 | 40 | 43 | 93.0% | |
| HF004 | 2016 | 47 | 49 | 95.9% | |
| HF004 | 2017 | 45 | 47 | 95.7% | |
| HF004 | 2018 | 49 | 50 | 98.0% | |
| HF004 | 2019 | 52 | 54 | 96.3% | |
| HF004 | 2020 | 49 | 53 | 92.5% | |
| HF006 | 2021 | 77 | 92 | 83.7% | |
| HF006 | 2022 | 83 | 85 | 97.6% | |
| HF006 | 2023 | 76 | 80 | 95.0% |
